证券之星消息，根据天眼查APP于3月1日公布的信息整理，科迈生物科技(苏州)有限公司种子+轮融资，融资额未披露，参与投资的机构包括华兰股份，晶泰控股，锡创投。 科迈生物科技(苏州)有限公司是一家成立于 2021 年的数字化抗体发现初创公司，由晶泰科技和百奥赛图联合创办，通过机器学习算法针对给定靶点表位从头设计生成 (de novo design)天然人源化、成药性高的抗体序列。数据来源：天眼查APP为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.